Pharmafile Logo
Pharmafocus logo
Advanced Search

alltrials

Showing 15 posts of 36 posts found.

Esbriet image

InterMune drops EMA lawsuit over data release

June 10, 2014
Research and Development, Sales and Marketing EMA, EU, Esbriet, Goldacre, InterMune, alltrials, lung

InterMune has ended a year-long legal spat with the European Medicines Agency over the potential release of data for its …

News
Lilly image

Lilly the latest to open up data

June 4, 2014
Medical Communications, Research and Development, Sales and Marketing Goldacre, NHS, alltrials, data, lilly, transparency, trials

Eli Lilly is to begin sharing its clinical trial data with scientific researchers through a website housing information from several …

News
EMA building

BMJ slams EMA ‘U-turn’

May 30, 2014
Medical Communications, Research and Development, Sales and Marketing BMJ, EMA, alltrials, data, transparency

The BMJ has attacked the European Medicines Agency for what it believes is a decision to ‘backtrack’ on public access …

News
Riwal image

Clinical trials transparency: the journey so far

May 12, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, alltrials, rawal, transparency

There has been considerable publicity over the last year or two about transparency of information in clinical trials. However, activity …

Feature
Tamiflu

Tamiflu stockpiling ‘unjustifiable’ and wasted £424m

April 10, 2014
Medical Communications, Research and Development, Sales and Marketing BMJ, Cochrane, Tamiflu, alltrials

Governments around the world may have squandered hundreds of millions of pounds on stockpiling Tamiflu, according to a review by …

News

Boehringer: ‘devil in detail’ on new drug pricing policy

April 10, 2014
Medical Communications, Sales and Marketing Boehringer, PPRS, VBP, Zinta Krumins, alltrials, vba

Zinta Krumins, the newly-appointed managing director of Boehringer Ingelheim UK and Ireland, has warned that the ‘devil is in the …

News
ema_building_face_web

EMA transparency agenda sees more delay

April 9, 2014
Medical Communications, Sales and Marketing AbbVie, EFPIA, EMA, Europe, InterMune, alltrials, parliament, transparency

The European Medicines Agency is to further delay its policy over clinical trial transparency, saying it needs more time to …

News
Abbvie image

AbbVie drops EMA legal case after compromise

April 4, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, EMA, alltrials

AbbVie will no longer seek to stop the European Medicines Agency from releasing data on its blockbuster arthritis treatment Humira. …

News
Glenis Willmott

EU votes for trial transparency

April 3, 2014
Research and Development, Sales and Marketing ABPI, EFPIA, EU, Goldacre, UK, alltrials, transparency, willmott

Europe took a decisive step toward forcing pharma to open up its clinical trial data last night, after the EU …

News
EU flag image

Data transparency debate: Europe decides its future

March 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, EU, Goldacre, NHS, alltrials, european, transparency

Transparency became a major issue in 2013 as various new pressure groups sprung up with the shared aim of forcing …

Feature
Clinical trials image

Clinical studies still not being published

March 4, 2014
Research and Development, Sales and Marketing ABPI, EMA, alltrials, clinical trials, csr

Half of all trials registered on a US clinical study database are not being published in public journals. This is …

News
Novartis image

Novartis extends trial transparency

February 27, 2014
Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Goldacre, Novartis, alltrials, transparency

Novartis has become the latest pharmaceutical company to allow greater scrutiny of its clinical trial data.

News
J&J image

J&J reveals more on transparency policy

February 3, 2014
Medical Communications, Research and Development, Sales and Marketing Goldacre, J&J, JJ, alltrials, johnson, transparency, yoda

Johnson & Johnson’s pharma subsidiary Janssen has given Pharmafile more details on its new transparency policy, which will see both …

News
GSK image

GSK and Sanofi expand transparency

January 6, 2014
Research and Development, Sales and Marketing GSK, Goldacre, Sanofi, alltrials, transparency

GlaxoSmithKline and Sanofi have announced separate moves which will shine greater light on both companies’ clinical trial data. GSK has …

News

Europe to vote on greater trial transparency

December 17, 2013
Research and Development, Sales and Marketing EU, Europe, Goldacre, alltrials, transparency

Pharma companies and academic researchers will be obliged to upload the results of all their European clinical trials to a …

News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026